Rupee at record low as Sensex slides; India markets under pressure
December 15, 2025, 1:55 AM EST. Indian equities opened in the red, with the Sensex down about 253 points and the Nifty 50 slipping below 26,000. At the opening bell, the Sensex was about 0.30% lower and the Nifty declined around 0.33%. The Nifty Auto was the biggest laggard, while Nifty Media was the lone sector in the green. Shares of ONGC, M&M, and Eicher declined, though Vodafone Idea rose. The rupee hit a record low of 90.58 per dollar, extending its fall after 90.55 last Friday. Analysts cite US tariffs on Indian goods, export concerns, a widening current account deficit, and strong dollar demand. Despite RBI interventions, the currency remains under pressure amid uncertainties in India-US trade negotiations.
ASX shares fall after damning ASIC inquiry as overhaul plan unveiled
December 15, 2025, 1:53 AM EST. Shares in ASX fell about 5.7% after ASIC-appointed experts said the exchange underestimated what it took to fix years of woes, was insular and defensive, with governance weaknesses and a weak culture around risk, compliance and stakeholder management. The panel-Rob Whitfield, Christine Holman and Guy Debelle-urged a stronger remediation program and leadership reform. ASX will reset its Accelerate program, appoint independent directors to its clearing and settlement subsidiaries, and hold an extra $150m in liquid assets. The move comes amid a line of problems-from outages to a botched IT project to move trades to blockchain. CEO Helen Lofthouse has faced pressure, and dividend payments to investors were slashed following a deal with ASIC. Treasurer Jim Chalmers and ASIC chair Joe Longo demanded lasting, tangible change.
Singapore Telecommunications (Singtel) Stock Outlook for 15 December 2025: Price, Forecasts and Key News (SGX: Z74)
December 15, 2025, 1:52 AM EST. Singapore Telecommunications (Singtel) traded around S$4.65 on 15 December 2025, as investors weigh a dual thesis: a steady telecom cash generator and a fast-expanding digital infrastructure platform. The stock's re-rating reflects asset recycling and higher shareholder returns, including a S$2 billion buyback and a raised asset-recycling target to S$9 billion. A stronger contribution from Optus and regional associates lifted H1 FY2026 underlying net profit by 14% to S$1.35 billion, with an upgrade to the OpCo EBIT growth outlook. Beyond traditional telco, Singtel's Nxera data-centre push and AI-driven demand underpin the bull case, while a narrowing holding-company discount supports upside if execution matches the narrative.
Analyst Upgrades Drive Focus on DRI Healthcare Trust Valuation and Growth Prospects
December 15, 2025, 1:51 AM EST. DRI Healthcare Trust's valuation update shows only modest changes, with Fair Value per unit easing from C$20.14 to C$19.91 while the discount rate stays near 6.12%, underscoring stable risk and capital cost assumptions. Revenue growth outlook nudged down to about 3.71%, reflecting a cautiously optimistic stance despite an active acquisition pipeline and long-term cash flow visibility. Analysts' price targets cluster in the C$19-C$21 range, bolstering the bulls' case, though some caution remains around valuation upside. Highlights include RBC Capital and CIBC upgrades, a sharp rise in impairment charges on royalty assets, a sizable share repurchase program, and a leadership transition in the CFO role that could aid execution and transparency. Investors may want to watch how these moving parts influence valuation and cash flow over the near term.
Corona Remedies Shares Rally 38% on NSE After IPO Listing
December 15, 2025, 1:47 AM EST. Corona Remedies made a confident market debut, listing at a premium on both NSE and BSE. The NSE listing price stood at ₹1,470, a 38.42% premium to the IPO price, while the BSE tick was ₹1,452, reflecting a 36.72% premium. Post-listing market capitalization hovered around ₹8,880.44 crore, signaling strong investor demand. The IPO was subscribed a stellar 137.04x, underscoring heavy interest across categories. The issue size was ₹655.37 crore with a price band of ₹1,008-₹1,062 and anchor investments of ₹195 crore. Headquartered in Ahmedabad, Corona Remedies operates in the pharmaceutical formulations space with a diversified portfolio of 67 brands across women's health, cardio-diabetes, pain management, urology, and more.
Analyst Upgrades Shape DRI Healthcare Trust Investment Narrative Amid Stable Valuation
December 15, 2025, 1:40 AM EST. Analysts push a more constructive view on DRI Healthcare Trust as fair value edges down to C$19.91 from C$20.14 while the discount rate stays at 6.12%. Revenue growth is nudged to ~3.71%. The story remains intact: a strong acquisition pipeline and long-term cash flow visibility, with targets clustered in C$19-C$21. Bullish signals: RBC Capital lifts its target to C$21 with an Outperform rating; CIBC raises to C$19.50 (Outperformer). Bearish note: upside appears capped near the low-C$20s if execution or deal flow slows. Notable updates: Q3 2025 impairment charges jump to $13.7 million; a buyback of ~1.4 million units for $13.74 million; CFO Zaheed Mawani named effective Oct 1, 2025 as part of a leadership transition.
AI Stocks Jump 257% and 316% in 2025 – Could 2026 Bring a Bust?
December 15, 2025, 1:37 AM EST. Three years after ChatGPT, AI remains the market's biggest trend. Large tech firms are ramping data centers, while memory and storage demand climbs. Seagate Technology (STX) has risen about 257%, and Western Digital (WDC) roughly 316%, driven by nearline storage needs near GPUs and AI workloads. The core HDDs underpinning nearline storage have benefited from OpenAI, Anthropic and others training models on billions of data points. But 2026 could bring a bust: expanding capacity may erode pricing power if demand cools, squeezing margins. WD projects supply constraints through mid-2027, and Seagate says much capacity is already contracted into 2026. Investors should balance continued AI-driven demand against the risk of higher costs and a softer cycle.
AI Storage Rally: Seagate and Western Digital Up 257% and 316% in 2025-Caution Ahead for 2026
December 15, 2025, 1:34 AM EST. Generative AI remains a defining market theme, driving skyscraping returns for storage names like Seagate Technology and Western Digital as demand for nearline storage soars. After a 257% jump for Seagate and a 316% surge for Western Digital in 2025, the thesis hinges on supply constraints and expanding capacity. Data centers and AI developers push demand for HDDs to store billions of model parameters, while margins widen as prices rise. But the story carries a caution: if capacity outpaces demand or pricing power erodes as supply grows, multiples could compress in 2026. The balance between expanding capacity and sustaining profitability will determine whether the nearline storage rally continues or cools.
Corona Remedies Debuts with 38% Premium on NSE; IPO Subscribed 137.04x
December 15, 2025, 1:33 AM EST.Corona Remedies opened strong on the NSE with a listing price of ₹1,470, delivering a premium of 38.42% over the IPO price. On the BSE, the stock listed at ₹1,452, up about 36.72%. The listing followed a robust primary issue, which was subscribed 137.04x, signaling solid investor demand. Post-listing, the company commands a market capitalisation of ₹8,880.44 crore. The IPO size was ₹655.37 crore, with a price band of ₹1,008-₹1,062 and anchor investments of ₹195 crore. Headquartered in Ahmedabad, Corona Remedies develops and markets pharmaceutical formulations across multiple therapies, including Women's health, Cardio-diabetes, Pain management, and Urology, with 67 brands as of Dec 2024. The debut sets a confident tone for the stock on listing day.
December 2025 European Stocks Trading Below Fair Value: A Look at Undervalued Names
December 15, 2025, 1:18 AM EST. As of December 2025, European markets show mixed momentum with DAX up and CAC 40 down, creating opportunities among stocks potentially trading below their fair value. The roundup highlights names with discounts to fair value of roughly 49% across several peers, including Unimot, Straumann, Sanoma, PVA TePla, Kitron, Inission, Gentili Mosconi, Exel Composites, Digital Workforce Services, and Allcore. Beyond the top-screened list, Laboratorios Farmaceuticos Rovi appears at a substantial discount to fair value (about 37.9%), with expected earnings growth ahead. Sweden's Apotea AB also trades beneath its estimated fair value by about 24.7%, supported by solid revenue growth and rising profitability. The screen emphasizes how cash-flow-based valuations can reveal compelling bargains amid rate worries and resilient eurozone growth.
Australian Shares Fall as ASIC Imposes AU$150 Million Capital Charge on ASX
December 15, 2025, 1:17 AM EST. Australian shares ended lower as investors digested Friday's tech rout in New York and weighed valuation and AI spend questions. The S&P/ASX 200 slipped 0.7% to finish at 8,635. Tech declines pressured sentiment amid concerns on returns from billions poured into AI, with insiders noting the cycle is entering the "rubber meets the road" phase. The ASIC ordered an additional AU$150 million capital charge on the ASX by June 30, 2027, pending the Accelerate program reset. ASX shares fell about 6%. In other news, Westgold Resources plans a spin-out to form Valiant Gold; 4DMedical won Health Canada approval, lifting its stock about 10%.
JPMorgan Sees Nifty 50 at 30,000 by End-2026: Base Case for India Equities
December 15, 2025, 1:16 AM EST. JPMorgan's base case for Indian equities envisions the Nifty 50 reaching around 30,000 by end-2026. Rajiv Batra, head of Asia equity strategy and co-head of global EM equity, says JPMorgan remains overweight on Indian equities as the earnings recovery gains traction. He highlights the prospect of double-digit earnings growth in the coming quarters, supporting a constructive view on India's market trajectory.
Corona Remedies IPO Debuts on NSE at ₹1,461, Up 37.57%; 144.5x Subscription
December 15, 2025, 1:02 AM EST. Corona Remedies staged a blockbuster debut, listing at ₹1,461 on NSE (up 37.57% vs ₹1,062), and ₹1,452 on BSE (up 36.72%). GMP pointed to a listing around ₹1,404.50, a ~32% premium to the upper band. The IPO was oversubscribed 144.54x, with retail bids at 30.39x, NII at 220.18x, and QIBs at 293.80x. The ₹655.37 crore OFS saw no fresh issue, with anchor investors including SBI MF and ICICI Prudential MF participating. Corona Remedies, headquartered in Gujarat, runs two plants and operates across women's health, cardio-diabetes, pain management, and urology, reporting ₹46.19 crore Q1 FY26 profit and ₹149.43 crore FY25 net profit.
Dow Jones Hits Record as Nasdaq Slumps in Intramarket Divergence
December 15, 2025, 12:47 AM EST. Stocks closed with the Dow posting a record high while the Nasdaq sagged, underscoring an intramarket divergence as investors rotate from tech into cyclicals and defensives. The week's action left the Dow up about 503 points (+1.05%), while the S&P 500 slipped and the Nasdaq 100 fell almost 2%. AI jitters-expensive valuations and capex outpacing earnings-were front and center, with Oracle missing revenue and guiding higher capex and Broadcom signaling margin pressure from a rising mix of AI chips. Looking ahead, traders will digest the combined October-November NFP report and the CPI print, with core inflation near 3% and two 25bp Fed cuts priced in for 2026. Confirmation from broader breadth will be key.
Genesis Energy (GEL) Up 52% YTD as RBC Reiterates Buy with $20 Target
December 15, 2025, 12:46 AM EST. Genesis Energy, L.P. (GEL) has risen over 52% year-to-date, driven by improving cash flow and a robust offshore pipeline portfolio. On Dec 1, RBC Capital's Elvira Scotto reiterated a Buy rating with a $20 target, noting strong Q3 2025 results and favorable offshore transportation dynamics. The company posted net income of $9.2 million in Q3 2025, reversing last year's loss, with management pointing to the midstream pipeline segment's favorable conditions and lack of weather disruptions. GEL operates as a diversified midstream energy MLP focusing on transportation, storage, and processing for crude oil and natural gas along the Gulf Coast. While profitability has been uneven over the past year, the stock's cash flow and an expandable available pipeline support its upside, per the RBC view.
EM currencies rally as dollar cycle turns; forint leads 2025 surge
December 15, 2025, 12:45 AM EST. Exchange traders say forint strength has helped Hungary shine as part of a broader EM currency rally, with volumes in the niche pair doubling since Trump took office and the dollar backdrop growing more volatile. The Hungarian unit is on track for its best year in a quarter century, contributing to a roughly 20% rise against the dollar this year, while the broader MSCI Emerging Market Currency Index nears a multi-year high. Analysts expect the trend to continue as investors diversify away from U.S. assets and reprice risk amid a shifting dollar cycle. IMF cautions remind markets of vulnerabilities, as currency moves affect debt, trade competitiveness, and capital inflows across countries from South Africa to Hungary.
Middle East Dividend Stocks Yielding Up to 8% Amid Market Cooling
December 15, 2025, 12:33 AM EST. Amid a market cooldown in the Middle East, UAE indices eased as oil slipped, nudging investors toward income from dividend stocks. The screen highlights yields in roughly the 3%-8% range, with standout names like Computer Direct Group at 8.00% and National General Insurance at 7.63%, plus Riyad Bank (6.66%) and Saudi Awwal Bank (6.18%). Dividend ratings vary, with several names rated highly. The review also flags Turkey plays such as Çelebi Hava Servisi (3.9% yield) and OYAK Çimento Fabrikalari (4.0%), where cash-payout coverage is a concern. In a volatile environment, income-focused investors may still find compelling Middle Eastern picks, but careful scrutiny of cash flow coverage remains essential.
11 Most Profitable NYSE Stocks to Buy Right Now – The AI Energy & Infrastructure Play
December 15, 2025, 12:27 AM EST. AI may be the biggest investment opportunity, but it's the energy footprint that could determine which stocks prosper. The piece argues that AI and its data centers push electricity demand higher, stressing power grids and pricing. While many investors chase flashy AI names, an overlooked NYSE stock-described as the "Toll Booth" Operator of the AI energy boom-owns critical nuclear energy infrastructure and can execute large EPC projects across oil, gas, renewables. It also plays a role in LNG export and could benefit from tariffs and onshoring trends under a renewed America First energy doctrine. The article touts this niche as a backdoor AI play and promises a broader list of 11 profitable NYSE stocks that capture the multi-cycle synergy of AI, energy, and infrastructure.
Abu Dhabi National Hotels Leads 3 Middle Eastern Penny Stocks To Consider
December 15, 2025, 12:20 AM EST. Markets across the Middle East have cooled as oil slips and profit-taking pressure stocks after a strong rally. Investors are turning to penny stocks that blend financial stability with growth potential. The article spotlights Abu Dhabi National Hotels Company PJSC (ADNH) as a regional example, noting a market cap near AED5.7B and diversified revenue from hotels, catering, and transport. ADNH shows solid EBIT coverage (7.2x) and a cautious net debt to equity ratio (~6.4%), but earnings growth has slowed and margins have narrowed; the dividend yield remains attractive though not fully covered by earnings or cash flow. Other screened peers include Al Wathba National Insurance and E7 Group, illustrating how selective names may offer upside in today's cautious market.
Indian shares slip on outflows, US trade deal uncertainty
December 15, 2025, 12:19 AM EST. Indian equities weakened in early trade as foreign outflows and US trade deal uncertainty weighed on sentiment. The Nifty 50 slipped 0.51% to 25,913.45, while the BSE Sensex declined 0.46% to 84,875.85 as of 9:30 a.m. IST. The rupee touched a record low around 90.56 per dollar. All 16 sector indices fell; small-caps and mid-caps shed about 0.2-0.5%. Investors faced a sixth straight session of selling, with total outflows this month near $2 billion and Friday's tally at ₹11.1 billion (~$122.6 million). The drag is the elusive U.S.-India trade deal, which could affect exports and widen the trade deficit. ONGC slumped ~3%, while KEC International jumped 3.5% on new orders; Axis Capital flagged a bearish ONGC outlook. Dollar around ₹90.63.
Huationg Global's ROCE Signals Growth Through Reinvestment (Catalist:41B)
December 15, 2025, 12:18 AM EST. An early indicator of value compounding is rising ROCE alongside expanding capital employed. Huationg Global (Catalist:41B) posts a trailing ROCE of 9.2%, in line with the industry average, and has grown capital employed by about 31% over five years as it moves from loss to profit. This suggests profitable reinvestment opportunities and the potential for compound earnings. The stock has performed well over the last five years, reinforcing investor interest. Risks include a high current-liabilities ratio at 53%, implying reliance on short-term creditors and suppliers. If these trends persist and leverage costs remain manageable, the stock could be a candidate for further upside, subject to ongoing profitability and reinvestment execution.
Suncor Energy Inc. (SU:CA) Stock Analysis and AI Trading Signals – Dec 14, 2025
December 15, 2025, 12:14 AM EST. According to Stock Traders Daily, updated AI-generated signals for Suncor Energy Inc. (SU:CA) on December 14, 2025, place a cautious long setup. The plan calls for a buy near 55.91 with a stop at 55.63; there are currently no short entries offered. The December 14 rating snapshot shows Near: Weak, Mid: Neutral, and Long: Neutral for SU:CA. With the timestamp noted as December 14, 2025, 11:50 PM ET, traders are reminded to monitor price action around the 55.91 level and manage risk accordingly. Overall, the signal suite favors a guarded stance, emphasizing price levels and risk controls while the AI model weighs multiple horizons.
ASX Limited falls after ASIC imposes $150m capital charge; governance overhaul underway
December 15, 2025, 12:13 AM EST. ASX Limited shares slid after the Australian Securities and Investments Commission announced a $150 million capital charge tied to an interim governance and operations review. The regulator flagged weaknesses in oversight, technology delivery, and risk management, noting that the exchange's focus on short-term performance compromised its role as critical market infrastructure. ASX has agreed to remedial actions, including reconstituting its clearing and settlement boards, boosting service-level standards, and accelerating its stalled technology transformation. To fund the reforms, the company will lower dividend payouts. The development dents sentiment as the stock sits in a downtrend since July, trading around $54 with a key support level near the prior late-October test. A break below could open additional downside.
Lululemon Stock: Price Pop Doesn't Signal Near-Term Sales Recovery (LULU)
December 15, 2025, 12:12 AM EST. Lululemon Athletica shares have risen on a price pop, but the move does not certify a near-term sales recovery. The analysis cautions that a higher price can reflect factors beyond fundamentals and may not imply improving demand, comparable-store sales, or margin expansion. Investors should distinguish a short-term price swing from durable top-line growth. Watch for seasonality effects, tough year-ago comparisons, and ongoing competitive pressures. The piece emphasizes that this is an informational view, not personalized investment advice, and notes the risk of loss in following any strategy.
Mizuho Upgrades Cousins Properties to Outperform, Emphasizing Balance Sheet and Sun Belt Focus
December 15, 2025, 12:05 AM EST. Cousins Properties (CUZ) earned an Outperform upgrade from Mizuho, which highlighted balance-sheet flexibility and improving conditions in the Sun Belt office markets. The note suggests lower execution risk versus peers and that Cousins' position in key markets could sharpen the investment narrative as it funds leasing costs and selective acquisitions. The main risk remains ongoing office demand pressure from remote and hybrid work. In Q3 2025, revenue rose year over year while net income remained modest, underscoring why balance-sheet strength matters for absorbing leasing volatility and potential tenant move-outs. Long-term models point to a $31.58 fair value with about 26% upside, though traditional weak demand and competition from flexible space could keep occupancy pressured.
Mizuho Upgrades Cousins Properties (CUZ) to Outperform on Balance-Sheet Strength and Sun Belt Exposure
December 15, 2025, 12:03 AM EST. Mizuho's upgrade of Cousins Properties to Outperform underscores the bulls-on-balance-sheet narrative for CUZ as the company leverages balance-sheet flexibility to fund leasing and selective acquisitions in a challenged office backdrop. The upgrade emphasizes Cousins' positioned exposure in key Sun Belt markets and suggests lower execution risk versus peers, but the core risk remains: ongoing remote/hybrid work pressures on office demand. Cousins' Q3 2025 results showed higher revenue versus a year ago while net income stayed modest, a mix that highlights why liquidity and balance-sheet strength matter to absorb leasing volatility and tenant move-outs. Analysts point to a fair value near $31.58, implying ~26% upside, though investors should weigh continued occupancy headwinds and competitive space pressures.
DraftKings Gains NY Market Share; Benchmark Keeps Buy, $37 Target
December 15, 2025, 12:02 AM EST. DraftKings (DKNG) is gaining market share in New York's sports betting market, with NY handle up 12.7% and revenue up 16.2% YoY through Week 12. Benchmark reaffirmed a Buy rating and a $37 target on December 1, noting DKNG's market-share gains despite an 8.3% hold rate vs. NY's 9.3% average. The state's balanced model supports margin expansion as FanDuel drives margins while DraftKings promotes handle growth, contributing to a positive trend for local betting outcomes. DKNG is also targeting Missouri, where a temporary mobile license clears the way for its 29th regulated state. While Benchmark sees value in DKNG, it notes some AI names may offer greater upside with different risk profiles.
DraftKings Expands NY Market Share, Missouri Rollout Underway
December 15, 2025, 12:01 AM EST. DraftKings (DKNG) is gaining market share in New York as benchmarks note strong growth: NY handle up 12.7% and revenue up 16.2% YoY. Benchmark reaffirmed a Buy rating and a $37 price target on December 1. In NY, DKNG's handle up 15.6% YoY and revenue up 13.1%, with a hold rate of 8.3% vs. state average of 9.3%. The state's balanced model supports margin expansion via FanDuel and handle growth from DraftKings, underpinning a positive trend for betting outcomes. DKNG is also expanding to Missouri with a temporary mobile license, the 29th state. As a digital sports entertainment and gaming company, it offers betting, DFS, online casino. The note suggests some traders prefer AI stocks for upside and links to a free report on the best short-term AI stock.
